Flavopiridol in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT00047203 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

NIH

Sponsor class

Conditions

Refractory Multiple Myeloma
Stage I Multiple Myeloma
Stage II Multiple Myeloma
Stage III Multiple Myeloma

Interventions

DRUG: alvocidib

Sponsor

National Cancer Institute (NCI)